A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country

Subjects

Subjects :

Infectious Diseases
General Veterinary
General Immunology and Microbiology
Public Health, Environmental and Occupational Health
Molecular Medicine

Details

ISSN :

0264410X

Volume :

41

Database :

OpenAIRE

Journal :

Vaccine

Accession number :

edsair.doi...........f0039d30ae1633561d007c9c2bff1de2

Full Text :

https://doi.org/10.1016/j.vaccine.2023.01.007